HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress.

Abstract
The mammalian pyruvate dehydrogenase complex (PDHC) is a mitochondrial matrix enzyme complex (greater than 7 million Daltons) that catalyzes the oxidative decarboxylation of pyruvate to form acetyl CoA, nicotinamide adenine dinucleotide (the reduced form, NADH), and CO(2). This reaction constitutes the bridge between anaerobic and aerobic cerebral energy metabolism. PDHC enzyme activity and immunoreactivity are lost in selectively vulnerable neurons after cerebral ischemia and reperfusion. Evidence from experiments carried out in vitro suggests that reperfusion-dependent loss of activity is caused by oxidative protein modifications. Impaired enzyme activity may explain the reduced cerebral glucose and oxygen consumption that occurs after cerebral ischemia. This hypothesis is supported by the hyperoxidation of mitochondrial electron transport chain components and NAD(H) that occurs during reperfusion, indicating that NADH production, rather than utilization, is rate limiting. Additional support comes from the findings that immediate postischemic administration of acetyl-L-carnitine both reduces brain lactate/pyruvate ratios and improves neurologic outcome after cardiac arrest in animals. As acetyl-L-carnitine is converted to acetyl CoA, the product of the PDHC reaction, it follows that impaired production of NADH is due to reduced activity of either PDHC or one or more steps in glycolysis. Impaired cerebral energy metabolism and PDHC activity are associated also with neurodegenerative disorders including Alzheimer's disease and Wernicke-Korsakoff syndrome, suggesting that this enzyme is an important link in the pathophysiology of both acute brain injury and chronic neurodegeneration.
AuthorsErica Martin, Robert E Rosenthal, Gary Fiskum
JournalJournal of neuroscience research (J Neurosci Res) 2005 Jan 1-15 Vol. 79 Issue 1-2 Pg. 240-7 ISSN: 0360-4012 [Print] United States
PMID15562436 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review)
Copyright(c) 2004 Wiley-Liss, Inc.
Chemical References
  • Pyruvate Dehydrogenase Complex
Topics
  • Animals
  • Brain Ischemia (enzymology, physiopathology)
  • Energy Metabolism
  • Enzyme Activation (genetics)
  • Frontal Lobe (enzymology)
  • Heart Arrest (enzymology, physiopathology)
  • Humans
  • Models, Biological
  • Neurodegenerative Diseases (enzymology, physiopathology)
  • Oxidative Stress (physiology)
  • Pyruvate Dehydrogenase Complex (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: